VDR and neoplasm: Moreover, anti‐tumour activity of the biologically active form of vitamin D, 1,25‐dihydroxyvitamin D3 (1,25‐(OH)2D3) acting via the vitamin D receptor (VDR), has been verified in human and rat prostatic tissue (Blomberg Jensen et al., 2011; Johnson et al., 1996; Kivineva et al., 1998).